Transforming the planning of surgical and interventional cardiac procedures.
XRnostics Ltd.
XRnostics Ltd.
↓
XRnostics Ltd. is a cardiac software development company operating in the $8bn global structural heart market.
We bring together leading clinical experts and world-class imaging scientists to revolutionize the planning of surgical and transcatheter cardiac procedures.
XRnostics Ltd. was born out of a research collaboration between King’s College London and Guy’s and St. Thomas’ NHS Foundation Trust.
Heart VRTM
Our transformational virtual reality-based tool for clinicians.
Heart VRTM has not been approved by any regulatory body and is not commercially available.
Designed for clinicians by clinicians.
Our transformational VR-based tool provides rapid, immersive visualization and is designed to positively impact patient care worldwide.
*Heart VR*TM is fully immersive and accurate with workflow advantages such as rapid loading and no 3D printing costs.
Heart VRTM has not been approved by any regulatory body and is not commercially available.
Our virtual reality-based technology is designed to optimize procedure planning.
-
Through virtual device placement and intuitive manipulation.
-
Compatible with the clinical environment and workflow.
-
No pre-segmentation of images required.
Compatible with Dynamic Echo, MRI and CT and designed to work for session sharing.
This positively impacts joint interactions, second opinions, and replay pre-processing.
XRnostics Ltd. has received support from:
